Quanta Inc (fka QNTA)

[Fdc4]

Second Quarter 2021 Highlights:



? Total revenue generated was USD $116,869;

? Gross margins remained above 60%;

? Cash on hand at the end of the quarter was over USD $277,000;

? Received a response from the U.S. Food and Drug Administration (FDA) on Pre-Investigational New Drug (Pre-IND) submission on Escozine® validating proof-of-concept study;

? Signed product endorsement agreement with Tony Hawk;

? Signed distribution agreement with leading international distributor bringing products to Mexico;

? Produced first batch of medical-grade Escozine® at in-house facility;

? Received product re-registration on Escozine® in the Dominican Republic (DR) as a natural alternative medicine in oncological treatments